Next Generation News and Research

RSS

Benefits of NIH funding through the Recovery Act

In advance of the one-year anniversary of the Recovery and Reinvestment Act's enactment on February 17, twenty of the nation's leading research institutions, patient advocates and biomedical industry have released a detailed report on how Recovery Act funding of medical research through the National Institutes of Health (NIH) is at work across the country in the service of better health and a healthier economy.

21 Jan 2010

BioLife Solutions announces biologic packaging products pre-filled with GMP biopreservation media

BioLife Solutions, Inc., a leading developer, manufacturer, and marketer of biopreservation tools for cells, tissues, and organs, and OriGen Biomedical, a leading provider of biologic packaging products for research and clinical blood and cell-based therapies, today announced that the companies will introduce sterile standard and custom biologic packaging products pre-filled with BioLife's serum-free, protein-free HypoThermosol® cell and tissue storage/transport media and CryoStor™ cryopreservation media.

21 Jan 2010

New effort to produce standardized DNA parts for reducing development time of synthetic biology in labs

With seed money from the National Science Foundation (NSF), bioengineers from the University of California, Berkeley, and Stanford University are ramping up efforts to characterize the thousands of control elements critical to the engineering of microbes so that eventually, researchers can mix and match these "DNA parts" in synthetic organisms to produce new drugs, fuels or chemicals.

21 Jan 2010

Congress urged to stop child maltreatment deaths

As part of a campaign to stop child abuse and neglect deaths, National Children's Alliance and its partners – the Every Child Matters Education Fund, the National Association of Social Workers, and the National District Attorneys Association – are running ads that urge Congress to address the fatalities that claim the lives of innocent children every day. Specifically, the advertisements ask Congress to hold hearings and provide emergency funds to stop state cuts in child protective services.

21 Jan 2010

Vivian and Seymour Milstein Family Heart Center to open to patients in February

Ushering in a new era in comprehensive cardiac care, the Vivian and Seymour Milstein Family Heart Center celebrated its opening today at NewYork-Presbyterian Hospital/Columbia University Medical Center.

21 Jan 2010

Kolltan Pharmaceuticals raises $10M for advancing its therapeutic development pipeline

Kolltan Pharmaceuticals, Inc., a next-generation oncology therapeutics company, announced today that it has raised $10 million in investments and related payments from an affiliate of Celtic Therapeutics Holdings L.P. (“Celtic Therapeutics”) and Tichenor Ventures, LLC.

20 Jan 2010

Researchers measure medical students' attitudes and beliefs about CAM

In the largest national survey of its kind, researchers from UCLA and UC San Diego measured medical students' attitudes and beliefs about complementary and alternative medicine (CAM) and found that three-quarters of them felt conventional Western medicine would benefit by integrating more CAM therapies and ideas.

20 Jan 2010

Welch Allyn Singapore moves to new, larger facility at Alexandra Techno Park

Welch Allyn, a leading global manufacturer of frontline medical products and solutions, today announced that it plans to design next generation digital connected products specifically for Asian and emerging markets at its new international research and development facility in Singapore. The company’s recent move to a larger facility in Alexandra Techno Park comes just six years after it opened its first Asia-based research and development center in Singapore, the company’s first such venture in the Asia-Pacific region.

20 Jan 2010

Corventis' NUVANT MCT System for detecting non-lethal arrhythmias receives FDA marketing clearance

Corventis, Inc., a developer of wireless cardiovascular solutions, announced today that it has received 510(k) clearance from the US Food and Drug Administration (FDA) to market its NUVANT™ Mobile Cardiac Telemetry (MCT) System for the detection of non-lethal arrhythmias. In addition, the company announced that its Monitoring Center has been approved by the Center for Medicare & Medicaid Services (CMS) as an Independent Diagnostic Testing Facility (IDTF). Corventis has also received approval to bill for services provided to patients with Medicare and several commercial insurers, paving the way for the NUVANT MCT System to be available across the United States.

19 Jan 2010

Affomix, City of Hope collaborate in exploring next generation sequencing using digital proteomics

Affomix Corporation, a pioneer in high performance antibody technology, announced today a collaboration with City of Hope focused on establishing the clinical utility of “digital proteomics” with next generation sequencers. One of the nation’s top cancer research and treatment centers, City of Hope is a leading provider of molecular diagnostic testing services and an innovator in clinical genetics research.

19 Jan 2010

Perseid Therapeutics to co-develop and commercialize next-generation CTLA4-Ig therapeutics

Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its majority-owned subsidiary, Perseid Therapeutics LLC, achieved a preclinical milestone under its collaboration with Astellas Pharma Inc. to co-develop and commercialize next-generation CTLA4-Ig therapeutics.

19 Jan 2010

Interdisciplinary nature of biological research triggers changes to JBC's publishing policies

The Journal of Biological Chemistry's editors are unveiling this week a number of changes to the journal's publishing policies. They say the changes are in response to the increasingly interdisciplinary nature of biological research and will help the journal better meet the evolving needs of the scientific community.

19 Jan 2010

HTI to deliver drinking water filtration systems to Haiti quake victims

Hydration Technology Innovations, LLC (HTI), the leading provider of next-generation forward osmosis water filtration technology, today announced it has teamed up with private donors to ship drinking water filtration systems to earthquake victims in Haiti.

19 Jan 2010

NIH awards IU School of Optometry $2.35M for glaucoma research

An Indiana University School of Optometry researcher's ongoing work to improve testing for and treatment of one of the world's leading causes of blindness will advance with support from a $2.35 million grant from the National Institutes of Health.

18 Jan 2010

Joubert Syndrome - an inherited neurological disease found among Ashkenazi Jews

Two scientists from Cold Spring Harbor Laboratory (CSHL) are part of an international team that has discovered a genetic mutation that causes Joubert Syndrome. JBTS, as it is commonly called, is a devastating inherited neurological disease that is very rare in the general population but found relatively more often among Ashkenazi Jews.

18 Jan 2010

Monsanto and Stokes Bio announce licensing agreement and R&D collaboration

Monsanto Company and Limerick-based biotechnology firm, Stokes Bio Limited, announced today that they have entered into a licensing agreement and R&D collaboration, which is expected to help accelerate the pace of new advancements in plant breeding.

13 Jan 2010

Kapa Biosystems signs non-exclusive North American distribution agreement with VWR International

Kapa Biosystems and VWR International, LLC announced today that they have entered into a non-exclusive North American distribution agreement for Kapa Biosystems' line of next-generation PCR reagents.

13 Jan 2010

KKESH in Saudi Arabia and U.S. Johns Hopkins Medicine announce collaboration

The Wilmer Eye Institute of Johns Hopkins Medicine in Baltimore (USA) announced today that it will collaborate in research, education and patient care with the King Khaled Eye Specialist Hospital in Riyadh (Saudi Arabia).

12 Jan 2010

QIAGEN N.V. announces acquisition of ESE GmbH for $19 million

QIAGEN N.V. today announced that it has acquired ESE GmbH, a privately held developer and manufacturer of UV and fluorescence optical measurement devices. ESE is based in Stockach, Germany. The transaction is valued at up to US$19 million in cash.

From QIAGEN Manchester Limited 12 Jan 2010

Pfizer commences SBI-087 Phase 2 clinical trial for RA

Trubion Pharmaceuticals, Inc. today announced that its collaboration partner, Pfizer, has initiated a Phase 2 clinical trial of SBI-087 (PF-05230895) for the treatment of rheumatoid arthritis (RA). SBI-087 is a next-generation, humanized Small Modular ImmunoPharmaceutical (SMIP(TM)) protein therapeutic directed against the CD20 antigen. SBI-087 is also being evaluated in Phase 1 clinical trials for RA and systemic lupus erythematosus (SLE).

12 Jan 2010

Next Generation News and Research

Benefits of NIH funding through the Recovery Act

BioLife Solutions announces biologic packaging products pre-filled with GMP biopreservation media

New effort to produce standardized DNA parts for reducing development time of synthetic biology in labs

Congress urged to stop child maltreatment deaths

Vivian and Seymour Milstein Family Heart Center to open to patients in February

Kolltan Pharmaceuticals raises $10M for advancing its therapeutic development pipeline

Researchers measure medical students' attitudes and beliefs about CAM

Welch Allyn Singapore moves to new, larger facility at Alexandra Techno Park

Corventis' NUVANT MCT System for detecting non-lethal arrhythmias receives FDA marketing clearance

Affomix, City of Hope collaborate in exploring next generation sequencing using digital proteomics

Perseid Therapeutics to co-develop and commercialize next-generation CTLA4-Ig therapeutics

Interdisciplinary nature of biological research triggers changes to JBC's publishing policies

HTI to deliver drinking water filtration systems to Haiti quake victims

NIH awards IU School of Optometry $2.35M for glaucoma research

Joubert Syndrome - an inherited neurological disease found among Ashkenazi Jews

Monsanto and Stokes Bio announce licensing agreement and R&D collaboration

Kapa Biosystems signs non-exclusive North American distribution agreement with VWR International

KKESH in Saudi Arabia and U.S. Johns Hopkins Medicine announce collaboration

QIAGEN N.V. announces acquisition of ESE GmbH for $19 million

Pfizer commences SBI-087 Phase 2 clinical trial for RA

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News